Consun Pharmaceutical Group
Consun Pharmaceutical Group Ltd is a Chinese pharmaceutical manufacturing enterprise headquartered in Guangzhou, Guangdong Province, China. The company specializes in the research, development, manufacturing, and distribution of proprietary Chinese medicines, modern prescription pharmaceuticals, and medical imaging contrast agents, focusing primarily on nephrology, urology, and specialized clinical treatments. Principal revenue is derived through wholesale manufacturing sales of pharmaceutical formulations to hospitals and drug distributors across China. Consun Pharmaceutical Group is publicly listed on the Hong Kong Stock Exchange.
3 of the funds FundTelligence covers report a position in Consun Pharmaceutical Group.
- Legal name
- CONSUN PHARMACEUTICAL GROUP LTD
- Sector
- Health Care
- Country
- China
- Funds holding it
- 3
Funds holding Consun Pharmaceutical Group
- Mercer Global Small Cap Equity Fund — Mercer · 0.08 % (full portfolio disclosed, December 2025)
- SEB Asienfond ex Japan — SEB · 0.05 % (full portfolio disclosed, June 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)